We identified 16 and 5 SuS-specific public clones in the total CD8+ T cell and CD8+ TEMRA repertoire, respectively, which were shared by at least two SuS patients, but absent in healthy individuals and MS patients (Table 1). This evidence concerns the gene CD8A and myeloid sarcoma.